• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    Axonics’ First US Patient Implanted with Sacral Neuromodulation System

    Jocelyn Aspa
    Nov. 01, 2019 09:44AM PST
    Medical Device Investing

    The implantation of the first patient in the US comes following the approval from the US Food and Drug Administration in September.

    Axonics Modulation Technologies (NASDAQ:AXNX) has announced that the first US-based patient has been implanted with its Axonics r-SNM System following clearance from the US Food and Drug Administration (FDA) in September.

    As quoted in the press release:

    Following the completion of customary post-approval regulatory activities, the first implant outside of a clinical study setting was conducted in California on October 29.

    “This first patient was a perfect candidate for the Axonics device,” said Felicia Lane, M.D., Director of Urogynecology, Obstetrics and Gynecology, University of California, Irvine School of Medicine. “Not only did our patient suffer with urinary and bowel dysfunction most of her adult life, her previously implanted SNM device required replacement due to battery depletion in less than four years. Just three short years after her second implant, the device failed due to a fractured lead wire requiring explantation of the entire system. We took this opportunity to implant the long-lived rechargeable system from Axonics which I consider to be state of the art in sacral neuromodulation. At UCI, we pride ourselves in providing our patients with the most effective and reliable treatments, and the Axonics system is a perfect example.”

    The Axonics r-SNM System offers a long-lived miniaturized neurostimulator that is approximately the size of a USB stick and is qualified to operate for at least 15 years. Unlike some active implantable devices, the Axonics device can safely be left in place during full-body MRI scans.

    The patient, Melissa Der Manouel, said, “The original implant gave me symptom relief and a new lease on life, but having to undergo surgery every few years was physically and emotionally taxing. When I learned about the small rechargeable Axonics device that will work for 15 or more years and is MRI compatible, it was the obvious choice. I’m grateful to have this opportunity to greatly improve my quality of life over the long term.”

    Click here to read the full press release.

     

     

    us food and drug administrationaxonics modulation technologiesnasdaq:axnxmedical device investingunited states
    The Conversation (0)

    Go Deeper

    AI Powered
    Stethoscope connected to a phone with medical data overlay.

    Top 5 Small-cap Medical Device Stocks (Updated January 2025)

    Solta Medical's Thermage FLX and TR-4 Return Pad Receive Registration Certifications in China

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    CDX:AU

    Applied UV

    AUVI:NSD

    ALR Technologies

    ALRT
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×